Calithera Biosciences Reports Fourth Quarter 2018 Financial Results and Recent Highlights

NEXT STORY
Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
PREV STORY
Geron Corporation Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Events
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology

                       Esperite (ESP): Patent granted in China for treatment of acute and chronic ...

author_avatar
NASDAQ Market News

Matinas BioPharma Presents Positive Preclinical Data of Orally Available DNA Vaccines at the 27th Annual European Congress of Clinical Microbiology and Infectious Diseases

BEDMINSTER, N.J., April 24, 2017 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), ...

author_avatar
NASDAQ Market News

Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models

MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News